WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Steven Michael Oliveira25.77%668,123$3.43MInsider
Franklin Resources Inc22.69%588,237$3.02MInstitution
Suvretta Capital Management LLC7.88%204,220$1.05MInstitution
Adage Capital Partners GP LLC7.30%189,188$970.53kInstitution
Janus Henderson Group PLC6.96%180,399$925.45kInstitution
J. Kevin Buchi2.01%52,097$267.26kInsider
Megan Boston1.00%25,927$133.01kInsider
Vanguard Group Inc0.64%16,701$85.68kInstitution
Geode Capital Management LLC0.39%10,024$51.42kInstitution
Morgan Stanley0.20%5,100$26.16kInstitution

1 of 2

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC46.20%28.78%
NNVC2.27%97.73%
NCNA29.52%0.00%
ABVC0.52%99.48%
EDSA1.29%98.71%Net BuyingNet Buying

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 46.20% institutional shareholders, 28.78% Benitec Biopharma insiders, and 25.02% retail investors. Steven Michael Oliveira is the largest individual Benitec Biopharma shareholder, owning 668,123.00 shares representing 25.77% of the company. Steven Michael Oliveira's Benitec Biopharma shares are currently valued at $3.51M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.